OncoC4
Operator of a biopharmaceutical company intended for the discovery of novel biologicals for cancer and neurodegenerative disease treatments. The company develops immunotherapy products targeting cance...
Valuation
$660M
Latest known
Share Price
N/A
Total Raised
$50M
Last Round
N/A